Holen Sie sich die Stockscreener-App
78.14
1.45%
-1.15
Handel nachbörslich:
79.70
1.56
+2.00%
Schlusskurs vom Vortag:
$79.29
Offen:
$79.34
24-Stunden-Volumen:
244.59K
Relative Volume:
0.42
Marktkapitalisierung:
$2.95B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-91.00M
KGV:
-21.29
EPS:
-3.67
Netto-Cashflow:
$-74.38M
1W Leistung:
-1.20%
1M Leistung:
-14.81%
6M Leistung:
+39.89%
1J Leistung:
+24.94%
1-Tages-Spanne:
$77.83
$80.53
1-Wochen-Bereich:
$76.19
$81.90
52-Wochen-Spanne:
$30.82
$99.50
Disc Medicine Inc Stock (IRON) Company Profile
Firmenname
Disc Medicine Inc
Sektor
Branche
Telefon
(617) 674-9274
Adresse
321 ARSENAL STREET, SUITE 101, WATERTOWN
Vergleichen Sie IRON mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IRON
Disc Medicine Inc
|
78.14 | 2.99B | 0 | -91.00M | -74.38M | -3.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Disc Medicine Inc Stock (IRON) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-03 | Fortgesetzt | Stifel | Buy |
| 2025-07-21 | Eingeleitet | Truist | Buy |
| 2025-07-03 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-06-11 | Fortgesetzt | Raymond James | Strong Buy |
| 2025-02-27 | Eingeleitet | TD Cowen | Buy |
| 2024-11-05 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-04 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-10-23 | Eingeleitet | Jefferies | Buy |
| 2024-10-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-08-22 | Eingeleitet | Wells Fargo | Overweight |
| 2024-04-01 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2023-12-19 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-06-09 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-06-07 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-05-17 | Eingeleitet | Raymond James | Outperform |
| 2023-04-28 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-04-21 | Eingeleitet | Stifel | Buy |
| 2023-04-20 | Eingeleitet | Morgan Stanley | Overweight |
| 2023-03-23 | Eingeleitet | BMO Capital Markets | Outperform |
| 2023-02-28 | Eingeleitet | SVB Securities | Outperform |
Alle ansehen
Disc Medicine Inc Aktie (IRON) Neueste Nachrichten
Aug Intraday: How supply chain issues affect Disc Medicine Inc. stockPrice Action & Daily Profit Focused Stock Screening - ulpravda.ru
Will Disc Medicine Inc. stock deliver strong dividend growthWeekly Trend Recap & Detailed Earnings Play Strategies - ulpravda.ru
How institutional buying supports Disc Medicine Inc. stockJuly 2025 Technicals & Technical Entry and Exit Tips - ulpravda.ru
How supply chain issues affect Disc Medicine Inc. stockWeekly Trading Summary & Intraday High Probability Setup Alerts - ulpravda.ru
Aug Selloffs: Why Disc Medicine Inc. stock is favored by top institutionsJuly 2025 Opening Moves & Growth Oriented Trade Recommendations - ulpravda.ru
All You Need to Know About Disc Medicine, Inc. (IRON) Rating Upgrade to Buy - MSN
Disc Medicine to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Why Disc Medicine Inc. stock is seen as undervalued2026 world cup usa national team round of 16 young talents transition play winner prediction tactical review - ulpravda.ru
Disc Medicine, Inc. (IRON) Stock Analysis: Strong Buy Ratings and a Promising 54.73% Potential Upside - DirectorsTalk Interviews
Disc Medicine’s Cash Runway And NDA Milestones Could Be A Game Changer For IRON - Sahm
Disc Medicine (NASDAQ:IRON) Insider Sells $511,485.00 in Stock - MarketBeat
Aug Catalysts: Will Disc Medicine Inc stock deliver strong dividend growth2025 Retail Activity & Safe Entry Momentum Tips - moha.gov.vn
Disc Medicine: RALLY-MF Data Validates Pipeline Optionality (NASDAQ:IRON) - Seeking Alpha
Disc Medicine (IRON) stock today: year-end rally keeps January FDA decision in focus - TechStock²
Precision Trading with Disc Medicine Inc. (IRON) Risk Zones - Stock Traders Daily
Disc Medicine, Inc. (IRON) Stock Analysis: Poised for 55% Upside Potential Amid Robust Analyst Confidence - DirectorsTalk Interviews
Disc Medicine Earnings Notes - Trefis
Analysts Conflicted on These Healthcare Names: Moderna (MRNA), Disc Medicine (IRON) and Sagimet Biosciences, Inc. Class A (SGMT) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK), Moderna (MRNA) and Disc Medicine (IRON) - The Globe and Mail
Analysts Have Conflicting Sentiments on These Healthcare Companies: AbbVie (ABBV), Disc Medicine (IRON) and BioMarin Pharmaceutical (BMRN) - The Globe and Mail
Disc Shares Slip Amid Report FDA’s Prasad is Skeptical of Bitopertin’s Efficacy - BioSpace
Avoiding Lag: Real-Time Signals in (IRON) Movement - news.stocktradersdaily.com
Breakouts Watch: Is Disc Medicine Inc. stock attractive for hedge fundsRisk Management & Free Growth Oriented Trading Recommendations - Улправда
Disc Medicine (NASDAQ: IRON) Stock Drops on FDA Voucher Speculation: Latest News, Analyst Forecasts, and What Investors Watch Next - ts2.tech
Breakout Watch: Can Disc Medicine Inc. stock deliver surprise earnings beatRisk Management & Technical Confirmation Trade Alerts - Улправда
Disc Medicine, Inc. (NASDAQ:IRON) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Can Disc Medicine Inc. stock deliver consistent earnings growthJuly 2025 Levels & Risk Controlled Swing Trade Alerts - Улправда
Stifel reaffirms Buy rating on Disc Medicine stock amid FDA review speculation - Investing.com Canada
Jefferies reiterates Buy rating on Disc Medicine stock amid FDA concerns - Investing.com Canada
Disc Medicine Stock Slides After FDA Fast-Track Approval Doubts Surface — Wall Street Calls It An ‘Overreaction’ - Asianet Newsable
Disc Medicine (IRON) Gains Confidence Despite Timeline Concerns - GuruFocus
Disc Medicine stock rating reiterated at Outperform by BMO amid FDA review - Investing.com
Disc Medicine (IRON) Maintains Positive Outlook Amid CNPV Skepti - GuruFocus
Disc Medicine drops on report of FDA skepticism over rare blood disorder drug - TradingView — Track All Markets
Disc Medicine (NASDAQ: IRON) Stock Tumbles on Insider-Selling Headlines as Bitopertin FDA Decision Nears — News, Analyst Forecasts, and What to Watch (Dec. 19, 2025) - ts2.tech
Disc Medicine Enters Oversold Territory (IRON) - Nasdaq
Disc Medicine (IRON) Shares Decline Over 14% - GuruFocus
FDA Fast-Track Review Challenges Impact Disc Medicine's (IRON) B - GuruFocus
Disc Medicine (NASDAQ:IRON) Shares Down 9% After Insider Selling - MarketBeat
Is Disc Medicine Inc. stock a buy before product launchesRate Hike & Expert Approved Momentum Trade Ideas - DonanımHaber
Aug Movers: Why Disc Medicine Inc stock is seen as undervalued2025 Earnings Impact & Capital Efficient Trading Techniques - moha.gov.vn
Downgrade Watch: Can Disc Medicine Inc. stock deliver surprise earnings beatJuly 2025 Recap & Daily Profit Focused Screening - Улправда
Disc Medicine (NASDAQ:IRON) Director Sells $68,968.38 in Stock - MarketBeat
symbol__ Stock Quote Price and Forecast - CNN
Short Covering: How analysts rate Disc Medicine Inc. stock todayFed Meeting & Weekly Setup with ROI Potential - Улправда
Hedge Fund Moves: Is Disc Medicine Inc. stock recession proofProduct Launch & Entry Point Confirmation Signals - Улправда
Is Disc Medicine Inc. stock attractive for hedge fundsChart Signals & Precise Swing Trade Entry Alerts - Bollywood Helpline
Disc Medicine Insider Sold Shares Worth $16,858,639, According to a Recent SEC Filing - marketscreener.com
Disc Medicine Insider Sold Shares Worth $1,194,372, According to a Recent SEC Filing - marketscreener.com
Kevin Bitterman Sells 62,693 Shares of Disc Medicine (NASDAQ:IRON) Stock - MarketBeat
Disc Medicine (NASDAQ:IRON) Insider William Jacob Savage Sells 13,093 Shares - MarketBeat
Finanzdaten der Disc Medicine Inc-Aktie (IRON)
Umsatz
Nettogewinn
Free Cashflow
ENV
Disc Medicine Inc-Aktie (IRON) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Khara Rahul | Chief Legal Officer |
Jan 02 '26 |
Sale |
78.69 |
6,500 |
511,472 |
37,793 |
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):